CHOOSE BY ALPHABET

A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | R | S | T | V | W | Y | Z

Enter our
BLOG

Follow HFN

News

Oct 02, 2013

HFN Advises Abbott Laboratories in Israeli Spin-off of Research-based Pharmaceuticals Business

HFN represented Abbott Laboratories in connection with the Israeli spin-off of its research-based pharmaceuticals business to a new company named AbbVie. The Israeli portion of the spin-off was part of the global separation of AbbVie from Abbott and required the joint efforts of HFN's Commercial, M&A and Tax departments.

The transaction was led by Commercial department head Amir Seraya, partner Nurit Dagan and Ron Ben-Menachem.

Back